Federal Guidelines established by the National Institute of Health, require that institutions conducting or sponsoring research using recombinant DNA molecules or synthetic nucleic acid molecules covered by the NIH Guidelines, be responsible for:
- Ensuring that the IBC has adequate expertise and training (using ad hoc consultants as necessary); and
- Providing appropriate training for the IBC Chair and members, principal investigators (PI), and laboratory staff
The Institutional Biosafety Committee Chair is responsible for ensuring that IBC members are appropriately trained. The Principal Investigator is responsible for ensuring that laboratory staff are appropriately trained. The institution is responsible for ensuring that the Principal Investigator has sufficient training, however, this responsibility may be delegated to the Institutional Biosafety Committee.
Contact: Carmen Schaar-Walden, Coordinator of Research Compliance, at 918-631-3310 or firstname.lastname@example.org
Contact: Dr. Estelle L. Levetin, Chair, Institutional Biosafety Committee, at 918-631-2764 or email@example.com